OP16.04: Effect of metformin in addition to an antenatal diet and lifestyle intervention on fetal growth and adiposity: the GRoW randomised trial | Zendy

Poprzeczny A.J. | Zendy; Louise J. | Zendy; Deussen A. | Zendy; Dodd J. | Zendy

Premium

OP16.04: Effect of metformin in addition to an antenatal diet and lifestyle intervention on fetal growth and adiposity: the GRoW randomised trial

Author(s) -

Poprzeczny A.J.,

Louise J.,

Deussen A.,

Dodd J.

Publication year - 2019

Publication title -

ultrasound in obstetrics and gynecology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.202

H-Index - 141

eISSN - 1469-0705

pISSN - 0960-7692

DOI - 10.1002/uog.20807

Subject(s) - medicine , overweight , gestation , pregnancy , body mass index , obesity , obstetrics , fetus , randomized controlled trial , metformin , endocrinology , diabetes mellitus , biology , genetics

Ultrasound assessment of fetal biometry and adiposity was done at 28 and 36 weeks’ gestation. Conclusion: We find no evidence that the addition of metformin to dietary and lifestyle advice in pregnancy for women who are overweight or obese has a clinically relevant effect on fetal biometry or adiposity. 1.The University of Adelaide, The Robinson Research Institute, and Discipline of Obstetrics and Gynaecology; Adelaide, South Australia, AUSTRALIA 2.The Women’s and Children’s Hospital, Women’s and Babies Division, Department of Perinatal Medicine; Adelaide, South Austral ia, AUSTRALIA 3.The University of Adelaide, School of Public Health; Adelaide, South Australia, AUSTRALIA Amanda J Poprzeczny1,2, Jennie Louise1, Andrea R Deussen1, Jodie M Dodd1,2

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research